To assess the safety and efficacy of a single fraction of radiotherapy using helical tomotherapy to treat bone metastases.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Cross Cancer Institute
Edmonton, Alberta, Canada
To deliver a single fraction of radiotherapy safely to patients with bone metastases using helical tomotherapy
To assess and quantify the acute toxicity of patients with bone metastases treated with helical tomotherapy.
To measure invivo dosimetry and compare delivered doses to computer-reconstructed dose distribution.
To determine the maximum tolerated does of palliative radiation give with helical tomotherapy in a single fraction.
To assess the efficacy (pain control) of radiotherapy given with helical tomotherapy.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.